Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Sundial vs. OrganiGram: Which Cannabis Stock Is a Better Buy?

Published 05/04/2021, 10:09 AM
Updated 05/04/2021, 11:30 AM
© Reuters.  Sundial vs. OrganiGram: Which Cannabis Stock Is a Better Buy?

Shares of cannabis concern Sundial Growers (NASDAQ:SNDL) are down 95% from their record highs, while shares of OrganiGram (OGI) are down 70%. While these names may appear to be attractive cannabis bets for contrarian investors, a closer look at these companies’ weak financials and steep valuations may tell a different story. Read on.Cannabis stocks have been volatile this year. Not dissimilar to most nascent industries, stocks prices in the cannabis space have experienced big spikes and sharp declines over the years. Several marijuana producers are still unprofitable and are burning cash at a rapid clip. This means they must regularly raise equity capital, which dilutes shareholder value.

However, investors are nevertheless bullish on the expanding pot market in North America and the prospect of pot legalization in the U.S. and several other regions. This potential makes the sector attractive to investors with large risk appetites.

With this in mind, we compare two beaten-down pot stocks—Sundial Growers (SNDL) and OrganiGram (OGI)—to evaluate which is a better cannabis bet right now.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.